Cargando…
Impact of Single Dose Praziquantel Treatment on Schistosoma haematobium Infection among School Children in an Endemic Nigerian Community
Schistosomiasis is prevalent in Nigeria, and the foremost pathogen is Schistosoma haematobium, which affects about 29 million people. Single dose of the drug praziquantel is often recommended for treatment but the efficacy has not been documented in certain regions. Therefore, this study was designe...
Autores principales: | Adewale, Babatunde, Mafe, Margaret A., Sulyman, Medinat A., Idowu, Emmanuel T., Ajayi, Morakinyo B., Akande, David O., Mckerrow, James H., Balogun, Emmanuel O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Parasitology and Tropical Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327198/ https://www.ncbi.nlm.nih.gov/pubmed/30630278 http://dx.doi.org/10.3347/kjp.2018.56.6.577 |
Ejemplares similares
-
Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium
por: Coulibaly, Jean T., et al.
Publicado: (2012) -
Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014) -
Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
por: King, C H, et al.
Publicado: (2000) -
Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
por: Coles, G C, et al.
Publicado: (2001) -
Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia
por: Mekonnen, Asaye, et al.
Publicado: (2013)